Canaccord Genuity Reiterates Buy on Axogen, Maintains $15 Price Target
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Caitlin Cronin has reiterated a Buy rating on Axogen (NASDAQ:AXGN) and maintained a $15 price target.
June 20, 2024 | 4:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Canaccord Genuity analyst Caitlin Cronin has reiterated a Buy rating on Axogen and maintained a $15 price target, indicating continued confidence in the company's performance.
The reiteration of a Buy rating and maintenance of a $15 price target by Canaccord Genuity suggests strong confidence in Axogen's future performance. This positive analyst rating is likely to boost investor sentiment and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100